iohexol has been researched along with Cancer of Cervix in 7 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ninety-three patients with cervical squamous carcinoma later than stage IIB were included in this study." | 1.38 | The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer. ( Fan, HX; Li, XS; Song, YL; Zhou, CW; Zhu, HX, 2012) |
| "Cervical tumors of 38 cervix cancer patients were scanned by T(1)-weighted dynamic contrast enhanced (DCE) MRI and then by DCE-CT on the same day." | 1.36 | Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. ( Haider, MA; Karczmar, GS; Milosevic, M; Stadler, WM; Yang, C; Yeung, I, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekdawi, SN | 1 |
| Stewart, JM | 1 |
| Dunne, M | 1 |
| Stapleton, S | 1 |
| Mitsakakis, N | 1 |
| Dou, YN | 1 |
| Jaffray, DA | 1 |
| Allen, C | 1 |
| Park, K | 1 |
| Kim, SM | 2 |
| Haider, MA | 3 |
| Milosevic, M | 3 |
| Yeung, IW | 2 |
| Yang, C | 1 |
| Stadler, WM | 1 |
| Karczmar, GS | 1 |
| Yeung, I | 1 |
| Li, XS | 1 |
| Fan, HX | 1 |
| Zhu, HX | 1 |
| Song, YL | 1 |
| Zhou, CW | 1 |
| Nordby, A | 1 |
| Halgunset, J | 1 |
| Haugen, OA | 1 |
7 other studies available for iohexol and Cancer of Cervix
| Article | Year |
|---|---|
Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.
Topics: Animals; Contrast Media; Female; Heterografts; Humans; Iohexol; Lipids; Liposomes; Mice, SCID; Micro | 2015 |
Spatio-temporal heterogeneity in tumor liposome uptake: Characterization of macro- and microdistribution.
Topics: Animals; Contrast Media; Female; Humans; Iohexol; Lipids; Microscopy, Fluorescence; Optical Imaging; | 2015 |
Interindividual variability of arterial impulse response to intravenous injection of nonionic contrast agent (Iohexol) in DCE-CT study.
Topics: Arteries; Computer Simulation; Contrast Media; Female; Humans; Injections, Intravenous; Iohexol; Ion | 2009 |
Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; | 2010 |
The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Chi-Square Distribution; Contrast Media; F | 2012 |
A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer.
Topics: Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Magnetic Resonance Imaging; M | 2013 |
Effects of radiographic contrast media on monolayer cell cultures.
Topics: Carcinoma in Situ; Cell Line; Cells, Cultured; Contrast Media; Diatrizoate Meglumine; Female; Humans | 1986 |